ORAL TABLET CONTAINING ASPIRIN AND NIACIN
PURPOSE: A complex formulation containing aspirin and niacin is provided to ensure convenience administration and reduce side effects of the niacin and aspirin. CONSTITUTION: A complex formulation contains aspirin and niacin which are coated with enteric polymer. The complex formulation is an inner...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | PURPOSE: A complex formulation containing aspirin and niacin is provided to ensure convenience administration and reduce side effects of the niacin and aspirin. CONSTITUTION: A complex formulation contains aspirin and niacin which are coated with enteric polymer. The complex formulation is an inner cored-tablet containing aspirin, and cored-tablet with outer layer of niacin. The enteric polymer is hydroxypropylmethylcellulose phthalate or metacrylic acid copolymer. A granule having the inner core-tablet and outer layer further contains excipient, binder, lubricating agent or disintegrant. The excipient is starch, sorbitol, citric acid, mannitol, sucrose, colloidal silica, spray dried-lactose, anhydrous lactose, dibasic calcium phosphate or micro crystalline cellulose. The disintegrant is lactose, starch, sodium starch glycolate, crospovidone, croscarmellose sodium or maltodextrin. |
---|